(MedPage Today) — The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable gastric or gastroesophageal junction cancer, the agency announced on Tuesday.
Approval stipulates use of…
Stress laid on proper hygiene to prevent shigella spread in Kerala
A total of 15 cases, including one death, have been reported across the State this month due to shigellosis, a...






